A. Bernady

发表

The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort.

C. Raherison-Semjen, M. Molimard, C. Nocent-Ejnaini, 2020, Respiratory medicine and research.

Comorbidities and COPD severity in a clinic-based cohort

C. Raherison, M. Molimard, F. Le Guillou, 2018, BMC Pulmonary Medicine.

[Costs of hospitalisation for exacerbations of COPD in patients receiving domiciliary rehabilitation].

A. Bernady, D. Romain, E. Etchamendy, 2011, Revue des maladies respiratoires.

Question 5. Stratégies de la réhabilitation respiratoire

G. Ninot, C. Chouaid, J. Lonsdorfer, 2005 .

Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients

A. Antoniadis, T. Similowski, P. Surpas, 2019, International journal of chronic obstructive pulmonary disease.

Translation and Cultural Adaptation of PROactive Instruments for COPD in French and Influence of Weather and Pollution on Its Difficulty Score

F. Hug, C. de Bisschop, V. Thomas-Ollivier, 2020, International journal of chronic obstructive pulmonary disease.

COPD_A_214410 471..478

F. Hug, V. Thomas-Ollivier, C. Bisschop, 2020 .

Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?

M. Zysman, C. Raherison-Semjen, M. Molimard, 2020, Respiratory medicine.

Lung function parameters in omalizumab responder patients: An interesting tool?

P. Berger, F. Pellet, S. Marchand-Adam, 2017, Allergy.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

N. Roche, B. Delclaux, P. Burgel, 2017, Revue des maladies respiratoires.

Sex-related differences and FEV1 decline among COPD patients: the French Palomb cohort

C. Raherison-Semjen, J. Moinard, M. Molimard, 2022, 06.03 - Tobacco, smoking control and health education.